Detailed introduction to methylchloroisothiazolinone

Methylchloroisothiazolinone (5-Chloro-2-methyl-4-isothiazolin-3-one, abbreviated as CMI), with the chemical formula C₄H₄ClNOS, is a highly effective, broad-spectrum organic compound that has gained significant prominence in industrial, personal care, and pharmaceutical fields due to its unique bactericidal and preservative properties. This article provides a comprehensive analysis of this controversial ingredient from five perspectives: chemical properties, mechanism of action, application areas, safety concerns, and alternative solutions.

I. Chemical Properties and Mechanism of Action

Methylchloroisothiazolinone is a white liquid with a pungent, aromatic odor. It has a melting point of 42–45°C and a boiling point of 109.7°C. It is soluble in organic solvents such as chloroform and methanol. Its core mechanism of action involves breaking the sulfhydryl bonds in microbial proteins, thereby inhibiting the transport of cellular active substances and the glucose oxidation process, ultimately leading to the death of bacterial, fungal, and algal cells. This property enables it to achieve highly effective bactericidal activity even at low concentrations (0.0015%–0.01%). Moreover, it is compatible with most surfactants and corrosion inhibitors, making it the “gold standard” in the field of industrial water treatment.

In industrial circulating water systems and oilfield injection systems, methylchloroisothiazolinone effectively controls the growth of microorganisms such as sulfate-reducing bacteria and iron-oxidizing bacteria, thereby preventing equipment corrosion and biofouling. Its degradation products are non-toxic and leave no residue, meeting environmental protection requirements and further solidifying its position in industries such as steelmaking, papermaking, and coatings.

II. The Double-Edged Sword Effect in Application Fields

1. The “Guardian” of the Industrial Sector

In industrial cooling water systems, methylchloroisothiazolinone (CMI) inhibits microbial metabolism, extending equipment service life by more than 30%. For example, after a steel plant adopted a composite water treatment agent containing CMI, the rate of heat exchanger fouling dropped by 85%, and annual maintenance costs were reduced by several million yuan. The "Kathon" formulation—a blend of CMI and methylisothiazolinone (MIT) at a ratio of 3:1—has become a classic combination for industrial corrosion prevention.

### 2. The “Controversial Player” in the Daily Chemical Industry

In rinse-off products such as shampoos and body washes, methylchloroisothiazolinone (MCI) helps prevent microbial contamination and extends the product’s shelf life to 2–3 years. However, its irritant properties have gradually drawn regulatory attention. The EU Cosmetics Regulation explicitly stipulates that the maximum allowable concentration of MCI in rinse-off products is 0.0015%, and it is prohibited from being used in combination with methylisothiazolinone (MIT). For leave-on products—such as creams and lotions—the use of MCI is completely banned. This restriction stems from numerous allergy cases: in 2018, a certain brand of shampoo containing MCI caused hundreds of consumers to experience scalp redness, swelling, and itching, ultimately forcing the company to recall the product.

### 3. “Potential Risks” in the Pharmaceutical Field

Although CMI is used as a prodrug for angiotensin-converting enzyme inhibitors, its neurotoxicity risk cannot be overlooked. Animal studies have shown that prolonged exposure to high concentrations of CMI may cause damage to the central nervous system, manifesting as memory impairment and decreased motor coordination. Although the risk at typical daily doses remains unclear, the incidence of chronic hand eczema among occupationally exposed populations—such as workers on cosmetic production lines—is three times higher than in the general population.

III. Safety Controversies and Regulatory Developments

1. Skin irritation and allergic reactions

The irritant properties of CMI are closely related to the chlorine atoms in its molecular structure. Clinical data indicate that approximately 2% to 5% of the population is allergic to CMI, with symptoms ranging from contact dermatitis to systemic contact dermatitis—a widespread rash occurring far from the site of initial contact. Infants and young children are at higher risk due to their immature skin barrier: in 2020, a certain brand of baby wipes containing CMI caused several infants to develop exudative rashes on their buttocks, triggering a class-action lawsuit filed by parents.

2. Controversy over carcinogenicity

During its decomposition, CMI may release formaldehyde, which has been classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC). Although the concentration of CMI in everyday use is far below the carcinogenic threshold, the risk of long-term cumulative exposure remains controversial. Some studies have indicated that occupational populations exposed to CMI exhibit a slightly higher incidence of nasopharyngeal cancer compared to the general population; however, a direct causal relationship has yet to be established. 3. Global Regulatory Trends

To reduce risks, many countries have already implemented restrictive measures:

- European Union: In 2017, CMI was banned from use in spray products to prevent inhalation exposure;

- Japan: Reducing the maximum permitted concentration of CMI in cosmetics to 0.001%;

- China: In accordance with international standards, the concentration of CMI in rinse-off products must not exceed 0.0015%, and labels are required to clearly indicate “Contains Methylchloroisothiazolinone.”

IV. Alternative Solutions and Future Prospects

Faced with regulatory pressure, the industry is accelerating the development of low-irritation preservatives.

- Phenoxyethanol: Relatively safe, but has a narrow antibacterial spectrum and needs to be used in combination with other ingredients.

- Xing Gan Chun: Naturally sourced, with both moisturizing properties and a higher cost;

- Plant extracts: such as cinnamaldehyde and eugenol, which exhibit broad-spectrum antibacterial activity but have relatively poor stability.

In the future, the application of CMI will become increasingly sophisticated: In the industrial sector, nano-encapsulation technology will be used to reduce the risk of direct contact; in the daily chemical sector, “additive-free” formulations will be developed or multi-component preservative systems will be adopted to strike a balance between safety and efficacy.

Methylchloroisothiazolinone is a “double-edged sword”: while its highly effective antimicrobial properties provide crucial assurance for industrial production and daily chemical products, safety concerns have also prompted the industry to continuously seek safer alternatives. For consumers, it’s important to carefully read ingredient lists when choosing products and avoid long-term use of leave-on products containing CMI. For businesses, compliant use and innovative R&D will be key to meeting regulatory and market challenges.